Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I interpret the note that you highlighted to mean IF Regen lost the suit and couldn't come up with the $1.5 million then they might have to sell some assets (the IP) to raise the money. That doesn't seem likely. Hopefully we'll get good news soon.
Above my pay grade! My understanding that there is a dollar amount in dispute, so if we were to lose we would owe that amount (and court costs), but couldn't be forced to give anything else.
If a court date has been set up then this matter is still pending.
I agree that lack of a resolution would be an impediment to getting a deal done, it just seems like such a minor matter to take care of (in the scheme of things) that I wonder why it hasn't been resolved?
What's the amount in dispute here, $1.5 million? Given some of the projections being tossed about as to Regen's value in a buyout/partnership, wouldn't it make sense for Koos to give them what they want and be done with it?
I'm holding as well, though admittedly I was hoping for some news once we became current. But as I've posted before, if our patents were that promising, big pharma would know it and we wouldn't be trading at pennies. A potential suitor could pay off the plaintiff in the lawsuit and buy us out today.
Whether it's a gem remains to be seem. I'm heavily invested, but when people throw out multi-dollar price targets, or post articles from years ago, or cite paid promotional articles as if they were news, then it seems less than legit. And throw in some uninspiring trading action,and here we are!
Whatever it is, it's getting a little uncomfortable. I was hoping Koos would have some news to disseminate after getting current. I've said before big pharma and other insiders probably know the value of our patents, and at some price level one would think buyers would overwhelm any manipulation from the MMs.
Excellent posts today. I am very familiar with Kite and agree with your dispelling the notion that Regen and Kite will follow the same trajectory. That's the same point I was trying to make with Enz*. I too think the best way forward for shareholders is for Koos to collaborate with other companies for some of our more promising patents. I can't see a buyout at this time being anywhere near as beneficial to the share price.
So with this and the "massive" implications you cite in post 88918, the stock has done what? I own millions of shares here and hope for a nice return, but in my opinion you do newbies a disservice by posting the same things over and over again and infer that investors will get rich soon. Obviously Koos has spent a lot of money and effort to get current and get his financial ducks in a row, so hopefully we hear something soon. But no matter how much experience we here might have in the markets, or in biotech, or years trading, there are many more out there who know a lot more. And if this stock was destined for huge price gains soon, it would not be trading where it is. GLTA
Comparisons to ENZ* are not valid and should not be taken seriously. That stock ran when the entire OTC was running wild. Look no further than the fact it is now trading at .13 despite having hit much higher. Of course, .13 on Regen would be a great return from here. We also have more shares outstanding. Also, who cares if they had 1 patent and we have many more? It's quality not quantity that counts. I believe big pharma knows what patents we own, and if our patents were that promising, the stock would not be trading where it is. All these patent filings and reactivations could be nothing more than throwing spaghetti against the wall to see what sticks. Please set realistic price targets, not the pie in the sky numbers being tossed around.
Time will tell.
I sold the last of my shares today. Wishing everyone the best of luck. We deserved to have been treated better.
I disagree on the value of posting old news. I'm excited about the opportunity here, but some of the posts, however well intentioned, give the stock the air of a P&D.
News from years ago is already baked into the price. Links to "articles" that are nothing more than paid promo pieces aren't helpful. Posters popping in occasionally with multidollar price targets by year end are laughable.
Investors bought the rumor of going pink current and sold the news. Hopefully next week Dr. Koos can give an operational update which can put the stock price on a more sustainable upward path.
We're all just guessing, because we have nothing else to go on.
That's an ignorant comment. The CEO of a public company has a duty to
keep shareholders informed. And since Shawn specifically said he was going to communicate more, and raised money to pay for that effort, his silence is particularly worrisome.
Maybe the information Shawn has been telling us simply isn't true. Maybe the income projections are overstated, maybe the Canadian property isn't worth anything, maybe the Sparta/Clear initiative is bogus. On the other hand, maybe none of the above is true but the revenue to be generated is not enough to ever turn a profit.
I'm really not bashing, but how can we not assume something is wrong when Shawn et al. simply won't talk to investors? The mechanism is there via the FAQ section on the website, so it would take a minimum of effort and money.
It's to the company's detriment as well as investors to have the share price so low, so it's hard to put a positive spin on this.
The most positive spin I could offer is that Shawn is arrogant and thinks it is beneath him to waste his time addressing shareholders. And our reaching out to him only makes him more stubborn about it. And that's the positive spin! LOL The more pessimistic scenario is that this investment has no chance of making any money, for a variety of reasons. Shawn knows it, as do the other board members, so why bother pretending?
Did Shawn ever respond to your email? The other two board members didn't respond to mine. It's hard to be optimistic about an investment where management never updates shareholders.
I posted some information on the other two board members, and I emailed both of them. For whatever reason Shawn seems to be in witness protection, so I'd suggest putting some pressure on the other two guys in hopes of getting somebody to recognize that they're running a public company and owe the shareholders periodic updates.
Maybe. But remember that shares of our stock are currency for future transactions and the lower share price translates basically to a currency devaluation. So allowing that to happen is gross negligence, especially where a little outreach to shareholders could turn that around. Unless there's nothing positive he can say, which is the worst case scenario I was suggesting.
I emailed both of the other board members today but didn't get a response, nor do I expect to. It would be so easy for Shawn to update us on things, and since he won't I think we have to at least consider a worse case scenario.
Gerry Miller and John O'bireck are the other board members of Ethema. I just emailed them both with a pretty straightforward message. Maybe if we all do this we can get some action here?
https://www.gmalaw.ca/gerald-miller/
https://www.zoominfo.com/p/John-Obireck/-2065558882
Thanks. He's never responded to mine either (although I've been respectful) but I don't think I could restrain myself if I tried reaching out again. Given his lack of communication, he may have quit and run away somewhere. How would we ever know? LOL
By any chance did you get a response to the email you sent to Shawn?
So will we see a big jump today? I don't have the science background but I do understand markets. I have a heavy investment here and think this will be a multi-bagger, just not to the extent some are predicting. I really hope I'm wrong.
I too want to thank you for all your excellent work, but respectfully think your price estimates are way too high. Comparisons to other companies are risky since every situation is different. All of our patents sound fantastic, and I don't have the background to truly assess their value. But big pharma certainly has that expertise, and had probably seen these patents, and I don't think we'd be trading at pennies if they were potentially worth a multi-dollar valuation. I hope I'm wrong, but I think people are setting themselves up to be disappointed.
I wouldn't count on anything he has told us in the past. He sees what is happening to the share price. He knows we want to hear from him more often and he said he would address that. It seems logical that if he had anything positive to report he would do so.
The explanation should have accompanied the quarterly. Who is advising this guy? He really is a disgrace as the CEO of a public company. The only thing that surprises me at this point is that people continue to defend him. I don't think he's done anything illegal that warrants getting the SEC involved, but if publicly calling him out on twitter gets him to treat shareholders a little better than I'm all for it.
It's really a helpless feeling. I wish I knew what to do instead of just venting on a message board. I've reduced my holdings by 2/3 over the last month, but there's not enough liquidity ie. buyers at this point and I'm not giving the rest of my shares away. Does anyone talk to Shawn any more?
Maybe folks can post to Ethema's twitter account, about our missing CEO. For all we know he's been hit by a bus! How would we know? Imagine dropping the filing but not having anything additional to say!
And that's why people are selling. This is basically a one man shop, and if it looks like that one man is hiding....
There are thousands of stocks investors can buy, so why should they put money here?
The Company hopes to be able to increase the communications with shareholders while remaining fiscally prudent. With less expensive methods of communication such as this FAQ section on the Company website and using Twitter the Company can afford to disseminate less significant news more affordably. Significant news will always be shared via press release. The Company has engaged a new firm to update and revamp its website and to make better use of social media.
This is from the FAQ section on the company's website, added about a month ago. The last tweet is dated July 27. My questions:
When will the additional 12 beds be available?
What is the status of the collaboration with Sparta, and the work on Clear?
Is Greenstone up for sale? Does Ethema own that facility? The sales proceeds would be most helpful for Ethema's operations and debt elimination.
Does Shawn have plans to expand to additional facilities? How will that effort be funded?
This is where just a little bit of effort on Shawn's part to communicate more would make such a difference. It's all good to have a long term perspective as an investor, but a little reassurance that the company is on the right path is needed. It's perplexing the Shawn remains silent.
I think a buyout is the logical next step, but I don't know why we'd have to be current for that to happen. Private companies get bought out all the time, so why would it matter about our status? Maybe something else is in the works after the last Q is filed?
True.
You're right about that because a big chunk of the shares sold today were mine ie. retail. And the people who criticize or say that I don't know how to trade in the OTC said the same thing when I sold shares at .0023. I hope this is the bottom because I still have shares, but I'm not counting on it. I don't trust Shawn, and the investors still here have to hope that there's an innocent reason that Shawn is not communicating with shareholders. And you know what they say about hope as an investment strategy.
The Company will add a chat-type feature to the website so that shareholders can submit questions. In the meantime, shareholders can continue to contact Shawn Leon via email or text to submit questions. We will do our best to summarize questions once a week and update the FAQ section on the website.
The above is from the website, added several weeks ago. It hasn't been updated since then, and Shawn doesn't respond to emails. This debacle is all on Shawn. We can't blame the OTC, or the MMs. Shawn is in hiding, and I suspect we'll find out why when the fins drop.
With this kind of price action, can we expect anything but a lousy quarterly report? And continued silence from Shawn?
I know for a fact that a lot of the selling you're seeing down here IS retail, investors that are moving money where they can expect a better return.
Based on the close in Australia, converting to dollars we should be trading at .039. I don't see how today's price action could be anything else than MM manipulation. What an arbitrage opportunity for someone with access to both the U.S. and Australian markets!